Robert W Carlson, MD Professor of Medicine Division of Oncology and Stanford Medical Informatics Stanford University Medical Center Stanford, California		Steven Shak, MD Chief Medical Officer Genomic Health Inc Redwood City, California
	William J Gradishar, MD Director, Breast Medical Oncology Associate Professor of Medicine Robert H Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine Chicago, Illinois		Eric P Winer, MD Director, Breast Oncology Center Dana-Farber Cancer Institute Associate Professor of Medicine Harvard Medical School Boston, Massachusetts
	Enza Esposito Luke, RN, MSN, ONP Oncology Nurse Practitioner Hematology/Oncology Medical Group of Orange County Orange, California

CONTENT VALIDATION AND DISCLOSURES

New Jersey State Nurses Association (NJSNA) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CNE activities. All relevant conflicts of interest that are identified are thoroughly vetted by NJSNA for fair balance, scientific objectivity of studies utilized in this activity and patient care recommendations. NJSNA is committed to providing its learners with high-quality CNE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CNE activity:

Dr Carlson — Consulting Fees: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Genomic Health Inc; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP; Contracted Research: AstraZeneca Pharmaceuticals LP. Dr Gradishar — Consulting Fees: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Sanofi-Aventis. Ms Luke — No financial interests or affiliations to disclose. Dr Shak — Salary: Genomic Health Inc; Patent Holder: Genomic Health Inc; Ownership Interest: Genomic Health Inc. Dr Winer — Consulting Fees: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Genomic Health Inc, Roche Laboratories Inc, Sanofi-Aventis; Contracted Research: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Roche Laboratories Inc, Sanofi-Aventis.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CNE activity: Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc. Research To Practice receives education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Genentech BioOncology/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

The following clinical content reviewers, Joanne Librie, RN, Bernadette Makar, MSN, ANP and Paula Mateo, RN, BA state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CNE activity of any amount during the past 12 months.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. New Jersey State Nurses Association (NJSNA), American Nurses Credentialing Center (ANCC), Research To Practice, Abraxis Oncology, AstraZeneca Pharmaceuticals LP, Genentech BioOncology and Genomic Health Inc do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of NJSNA, ANCC, Research To Practice, Abraxis Oncology, AstraZeneca Pharmaceuticals LP, Genentech BioOncology or Genomic Health Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.